No Matches Found
No Matches Found
No Matches Found
Tianjin Ringpu Bio-technology Co., Ltd.
Tianjin Ringpu Stock Hits Day Low of CNY 18.43 Amid Price Pressure
Tianjin Ringpu Bio-technology Co., Ltd. saw a significant stock decline today, contrasting with the broader market's performance. Despite recent challenges reflected in its stock's longer-term underperformance, the company reported positive financial metrics, including increased net sales and profit for the nine-month period ending September 25.
Tianjin Ringpu Bio-technology Hits Day High with 5.71% Surge
Tianjin Ringpu Bio-technology Co., Ltd. saw a significant intraday increase on March 6, 2026, outperforming the China Shanghai Composite. Despite a weekly decline, the company has shown a yearly return of 15.19%. With a market cap of CNY 6,171 million, it maintains a dividend yield of 2.28%.
Tianjin Ringpu Bio-technology Co., Ltd. Reports Strong Financial Performance in Q1 2025
Tianjin Ringpu Bio-technology Co., Ltd. reported strong financial results for the quarter ending March 2025, with net sales reaching CNY 2,129.34 MM, a significant year-over-year increase. The company achieved record operating cash flow, high inventory turnover, and improved liquidity, reflecting effective management and operational efficiency.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
